At a glance
| Our verdict | Lowers LDL a little, and helps blood sugar when it is raised. Barley beta-glucan first; oat beta-glucan if avoiding gluten; psyllium only with published heavy-metal results. |
| Best use | Cholesterol and blood sugar |
| How sure the evidence is | Moderate for LDL; Very low for chemicals |
| Cost a month | About $47 to $64 (barley beta-glucan product); oats $5 to $10 |
Written for adults in Canada. It explains the evidence; it is not advice for you personally. Last reviewed 20 October 2026.
Supplement Check
Is it right for you?
Fibre suits most people, but whether it is the right step for you depends on your LDL, your blood sugar, your gut and the medicines it must be spaced from. Your check looks at all of it, and says when a medicine would do more. Our Supplement Check looks at:
- Difficulty swallowing, a narrowing of the gullet or bowel, a previous bowel blockage, a slow-emptying stomach (gastroparesis), or recent bowel surgery
- A doctor has told you to limit fluids
- Coeliac disease or gluten sensitivity
- Diabetes treated with insulin or a sulfonylurea
- LDL of 5.0 mmol/L or more, or a condition where a statin is advised and none is taken
- Every medicine you take
Coming soon. The Supplement Check and the Online Health Assessment open once our safety testing is complete.
$59 when it opens, paid once. Adults 18 and over, anywhere in Canada. While the service is new, Dr. French reads every report himself, and your report arrives within 3 working days. More about the Supplement Check
What it is
Soluble fibre is the kind that forms a gel in water. The main forms are beta-glucan from barley or oats, and psyllium husk.
Dr. French's order: barley beta-glucan first; oat beta-glucan from certified gluten-free (purity-protocol) oats for anyone avoiding gluten; psyllium only from a brand that publishes its heavy-metal test results, because psyllium can carry lead and arsenic.
About the barley product, honestly. It is sold in Canada as a food, not as a licensed natural health product, so it has no NPN. The grams of beta-glucan per serving are not printed (about 1 g per tablespoon, worked out from the maker's own figures), and the maker does not publish heavy-metal or mould-toxin results. It “contains trace amounts of gluten because it's extracted from barley” (maker's words), so it is not for anyone who must avoid gluten. We have not yet named an oat beta-glucan product, and on 14 Oct 2026 we found no psyllium brand in Canada that publishes its heavy-metal results.
How it acts
In the gut the gel slows the absorption of sugar, and it binds bile acids so they leave in the stool. The liver then uses cholesterol to make new bile, and LDL falls. This effect depends on the fibre being thick (high molecular weight): oat bran with native beta-glucan raised bile acid loss by 144% in 9 people with an ileostomy, [1] and 3 g of high-molecular-weight barley beta-glucan raised bile acid production, while a low-molecular-weight form, even at 5 g, did not. [2, 3]
Anything carried in bile can in theory be carried out with it, including some long-lasting chemicals. That is the mechanism behind the “binding” claims; it has been shown for prescription resins, not for fibre (see below).
What it is used for, and what the evidence says
| Use | What the trials found | How sure we are |
|---|---|---|
| LDL cholesterol, barley beta-glucan | 14 trials, 615 people, a median of 6.5 g a day: LDL 0.25 mmol/L lower. Apolipoprotein B (the number of LDL-type particles) did not change significantly. [4] | Moderate |
| LDL cholesterol, psyllium | 28 trials, 1,924 people, about 10 g a day: LDL 0.33 mmol/L lower, non-HDL cholesterol 0.39 lower, apolipoprotein B 0.05 g/L lower. [5] | Moderate |
| Blood sugar in type 2 diabetes | Viscous fibre, 28 trial comparisons, 1,394 people, about 13 g a day on top of usual care: average blood sugar (HbA1c) 0.58% lower, fasting glucose 0.82 mmol/L lower. [6] Psyllium: HbA1c 0.97% lower in diabetes, a modest effect in prediabetes and none with normal blood sugar; this review was written by employees of the maker of Metamucil. [7] | Moderate |
| Blood sugar, oat or barley beta-glucan extracts | Oat beta-glucan 2.5 to 3.5 g a day, 4 short trials, 350 people with diabetes: HbA1c 0.21% lower. [8] Across 18 trials, whole oats and oat bran lowered HbA1c, but oat or barley beta-glucan extracts did not reach significance. [9] That matters for the barley product we use, which is a barley extract. | Low |
| Triglycerides | Neither the barley nor the psyllium reviews found a fall. [4, 5] In diabetes, a network review ranked other fibres (guar, fenugreek), not beta-glucan or psyllium, for triglycerides. [10] We do not recommend fibre for triglycerides. | Very low |
| Long-lasting chemicals (PFAS, pesticides) | The “binding” idea is proven for prescription resins: cholestyramine halved the time the pesticide chlordecone stayed in the blood of 22 poisoned workers (165 to 80 days), [11] and 12 weeks of colesevelam lowered blood PFOS by 38% against 2% in 10 highly exposed adults. [12] For fibre itself, the only study in people is an exploratory analysis of a 4-week trial in 72 Canadian men: total PFAS fell in both groups, and long-chain PFAS fell only in the oat beta-glucan group; the difference between groups was not reported. [13] In a US survey, people eating more fibre had 4 to 8% lower PFAS levels, but that is an association, not proof. [14] | Very low (fibre) |
| Heavy metals and mould toxins | No study of oat or barley beta-glucan. One good trial of a different fibre (inulin 10 g a day) in 29 people on dialysis lowered blood arsenic by 1.03 µg/L from a starting level of 3.5. [15] No study in people of any fibre against mould toxins. | Very low to none |
| Heart attacks, strokes, deaths | No trial of a fibre supplement has measured them. In long-term studies, people eating more fibre from food had 15 to 30% lower death rates, less heart disease, type 2 diabetes and bowel cancer. [16] | Low (food fibre) |
How sure we are: High means further research is very unlikely to change the answer; Moderate, it might; Low, it may well change; Very low, we are very unsure. These follow the GRADE method that guideline panels use.
Benefits
- LDL cholesterol: 0.25 to 0.33 mmol/L lower (about 5 to 10%); Moderate
- HbA1c, type 2 diabetes: 0.2 to 0.6% lower; Moderate
- HbA1c, normal blood sugar: No change; Moderate
- Triglycerides: Not shown; Very low
- PFAS and other long-lasting chemicals: Possible small help; not measured properly; Very low
- Heavy metals, mould toxins: Not shown; Very low to none
Risks and side effects
- Gas and bloating. Start low and build up.
- Blockage of the gullet or bowel if taken without enough water, especially with swallowing problems, Parkinson disease, a previous bowel narrowing or a gastric band (case reports with psyllium).
- Allergy to psyllium, mostly in people who handle it at work.
- Heavy metals in psyllium, which is why we use only a brand that publishes its results.
- Gluten: the barley product contains traces.
Interactions with medicines
Fibre does not change how the liver clears medicines. Its interactions come from slowing or reducing absorption in the gut, and from lowering blood sugar.
| Medicine | What can happen | What to do |
|---|---|---|
| Most tablets and capsules | Less absorbed if taken together | Take other medicines at least 2 hours before or after |
| Levothyroxine | Less absorbed | Space by 4 hours |
| Lithium, digoxin, carbamazepine, warfarin | Small changes in absorption matter for these | Blood level or INR checked after starting |
| Insulin, gliclazide, glyburide, glimepiride | Blood sugar may fall too far | Held for a doctor |
Who should not take it
- Difficulty swallowing, a narrowing of the gullet or bowel, a previous bowel blockage, a slow-emptying stomach (gastroparesis), or recent bowel surgery.
- A doctor has told you to limit fluids.
- Coeliac disease or gluten sensitivity: not the barley product; oat beta-glucan from purity-protocol oats instead (most people with coeliac disease tolerate these; a minority react to oats).
- Diabetes treated with insulin or a sulfonylurea: a doctor first.
- LDL of 5.0 mmol/L or more, or a condition where a statin is advised and none is taken: see a doctor; fibre is not a substitute.
- Older adults: split the dose and take it with a full glass of fluid.
- Pregnancy and breastfeeding: no concern from fibre itself.
- Under 18: outside the Supplement Check.
Dose and timing
- Barley beta-glucan product: 3 tablespoons a day for about 3 g of beta-glucan, the amount behind Health Canada's cholesterol claim. Start with 1 tablespoon a day for a week. Mix in at least 250 mL of fluid and split across meals.
- Avoiding gluten: oat beta-glucan from purity-protocol oats, 3 g a day.
- Psyllium (only a brand with published heavy-metal results): 7 g of soluble fibre a day for LDL (about 10 g of husk), each dose with 250 mL of water; before meals when the aim is blood sugar.
- For chemicals: no dose is established. The only study used oat beta-glucan with each meal for 4 weeks. [13]
- Space other medicines by 2 hours (levothyroxine 4 hours).
- How to tell it is working: LDL (with non-HDL cholesterol or apolipoprotein B) at 6 to 12 weeks, expecting about 0.25 to 0.33 mmol/L lower; HbA1c at 3 months if your blood sugar is raised. There is no practical test for chemical binding.
- Food first: oats, barley, beans, lentils, vegetables and fruit every day.
- Store sealed, cool and dry.
What we know about Canadians
Almost no one in Canada eats enough fibre. In the 2015 national nutrition survey, men averaged 18.4 g a day and women 16.2 g, against targets of 38 g and 25 g (30 g and 21 g after 50). Only 1 to 6% of men and 4 to 22% of women reached the target. [17] These figures count fibre naturally present in food only, so true intake is slightly higher, but not by enough to change the picture.
Most at risk: nearly everyone; men most; diets low in whole grains, legumes, vegetables and fruit.
How sure are we: moderate. National survey, but based on recalled food and 11 years old.
An honest comparison: LDL cholesterol
The same outcome, in the same units, with the cost a month in Canadian dollars.
| Option | Effect | How sure we are | Cost a month (CAD) |
|---|---|---|---|
| Psyllium about 10 g a day (published heavy-metal results only) | LDL 0.33 mmol/L lower [5] | Moderate | $10 to $20 |
| Barley beta-glucan product | LDL 0.25 mmol/L lower [4] | Moderate | $47 to $64 |
| Portfolio eating (oats or barley, nuts, soy, plant sterols together) | LDL 0.73 mmol/L lower (about 17%) [18] | High | Food roughly neutral; dietitian about $30 |
| Statin, moderate dose (atorvastatin 10 mg, generic) | LDL 1.8 mmol/L lower (40%) from 4.8 [19] | High | $10 to $20 |
| Ezetimibe 10 mg | LDL 18.6% lower [20] | High | $15 to $25 |
Read honestly: for LDL, a statin does 6 to 7 times what fibre does, at about a third of the barley product's monthly cost. Fibre is an add-on, or a choice for people below the point where a statin is advised. For blood sugar in type 2 diabetes, viscous fibre does about half of what metformin does (HbA1c about 1.1% lower); [21] beta-glucan extracts do much less.
Our verdict
For adults with a raised LDL cholesterol below the level where a statin is advised, or with raised blood sugar (prediabetes or type 2 diabetes), alongside food: barley beta-glucan first, oat beta-glucan if you avoid gluten, psyllium only from a brand that publishes heavy-metal results. For smokers and people exposed to fumes at work it is part of the package with sulforaphane and sauna, with the honest wording: it may help the body clear some long-lasting chemicals; it has not been shown to remove them, nor heavy metals or mould toxins.
Not for triglycerides, not for normal blood sugar, and not instead of a statin or metformin when one is advised.
Soluble fibre carries bile out of the body, which is how it lowers cholesterol, and it has moderate-certainty evidence for a small fall in LDL and in raised blood sugar. It is cheap as food and safe for most people. Medicines do more, and we show that side by side. Prescription resins that work the same way speed the removal of some long-lasting chemicals, such as PFOS; for fibre itself that has only been tested in small, early studies, so we say “may help”, never “removes”. Dr. French's order (barley first, oat beta-glucan for gluten avoiders, psyllium only with published heavy-metal results) puts purity and gluten first. It is worth taking for cholesterol and blood sugar anyway, and that is the main reason we recommend it.
Supplement Check
Before you buy it, get it checked
Fibre suits most people, but whether it is the right step for you depends on your LDL, your blood sugar, your gut and the medicines it must be spaced from. Your check looks at all of it, and says when a medicine would do more. Our Supplement Check looks at:
- Difficulty swallowing, a narrowing of the gullet or bowel, a previous bowel blockage, a slow-emptying stomach (gastroparesis), or recent bowel surgery
- A doctor has told you to limit fluids
- Coeliac disease or gluten sensitivity
- Diabetes treated with insulin or a sulfonylurea
- LDL of 5.0 mmol/L or more, or a condition where a statin is advised and none is taken
- Every medicine you take
Coming soon. The Supplement Check and the Online Health Assessment open once our safety testing is complete.
$59 when it opens, paid once. Adults 18 and over, anywhere in Canada. While the service is new, Dr. French reads every report himself, and your report arrives within 3 working days. More about the Supplement Check
Disclosure of financial interest
White Pine Medical earns money from products bought through our Fullscript dispensary. Dr. French's Code of Ethics requires him to tell you this. You do not have to buy anything from us: every product is named by its ingredient and dose so you can buy it at any pharmacy, and the advice is the same wherever you buy it, or if you buy nothing.
References
- Ellegård L, Andersson H. Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur J Clin Nutr. 2007;61(8):938-45.
- Wang Y, Harding SV, Thandapilly SJ, Tosh SM, Jones PJH, Ames NP. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. Br J Nutr. 2017;118(10):822-9.
- Thandapilly SJ, Ndou SP, Wang Y, Nyachoti CM, Ames NP. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals. Food Funct. 2018;9(6):3092-6.
- Ho HV, Sievenpiper JL, Zurbau A, Blanco Mejia S, Jovanovski E, Au-Yeung F, et al. A systematic review and meta-analysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction. Eur J Clin Nutr. 2016;70(11):1239-45.
- Jovanovski E, Yashpal S, Komishon A, Zurbau A, Blanco Mejia S, Ho HVT, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2018;108(5):922-32.
- Jovanovski E, Khayyat R, Zurbau A, Komishon A, Mazhar N, Sievenpiper JL, et al. Should viscous fiber supplements be considered in diabetes control? Results from a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2019;42(5):755-66.
- Gibb RD, McRorie JW, Russell DA, Hasselblad V, D'Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. 2015;102(6):1604-14.
- Shen XL, Zhao T, Zhou Y, Shi X, Zou Y, Zhao G. Effect of oat β-glucan intake on glycaemic control and insulin sensitivity of diabetic patients: a meta-analysis of randomized controlled trials. Nutrients. 2016;8(1):39.
- He LX, Zhao J, Huang YS, Li Y. The difference between oats and beta-glucan extract intake in the management of HbA1c, fasting glucose and insulin sensitivity: a meta-analysis of randomized controlled trials. Food Funct. 2016;7(3):1413-28.
- Juhász AE, Greff D, Teutsch B, Gede N, Hegyi P, Horváth EM, et al. Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis. Am J Clin Nutr. 2023;117(2):266-77.
- Cohn WJ, Boylan JJ, Blanke RV, Fariss MW, Howell JR, Guzelian PS. Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial. N Engl J Med. 1978;298(5):243-8.
- Andersson AG, Xu Y, Kärrman A, Cederlund J, Lindh CH, Pineda D, et al. Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden. Environ Int. 2025;204:109794.
- Schlezinger JJ, Bello A, Mangano KM, Biswas K, Patel PP, Pennoyer EH, et al. Per- and poly-fluoroalkyl substances (PFAS) in circulation in a Canadian population: their association with serum-liver enzyme biomarkers and piloting a novel method to reduce serum-PFAS. Environ Health. 2025;24(1):10.
- Dzierlenga MW, Keast DR, Longnecker MP. The concentration of several perfluoroalkyl acids in serum appears to be reduced by dietary fiber. Environ Int. 2021;146:106292.
- Li L, Zhao J, Wang J, Xiong Q, Lin X, Guo X, et al. The arsenic-lowering effect of inulin-type prebiotics in end-stage renal disease: a randomized crossover trial. Food Funct. 2024;15(1):355-71.
- Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393(10170):434-45.
- Ahmed M, Praneet Ng A, L'Abbe MR. Nutrient intakes of Canadian adults: results from the Canadian Community Health Survey (CCHS)-2015 Public Use Microdata File. Am J Clin Nutr. 2021;114(3):1131-40.
- Chiavaroli L, Nishi SK, Khan TA, Braunstein CR, Glenn AJ, Mejia SB, et al. Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials. Prog Cardiovasc Dis. 2018;61(1):43-53.
- Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326(7404):1423.
- Pandor A, Ara RM, Tumur I, Wilkinson AJ, Paisley S, Duenas A, et al. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials. J Intern Med. 2009;265(5):568-80.
- Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ. Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care. 2012;35(2):446-54.
Costs marked as estimates are typical Canadian retail or pharmacy prices, before any drug plan. Certainty grades are ours unless the review gave its own.